These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16313234)

  • 21. Relation mining experiments in the pharmacogenomics domain.
    Rinaldi F; Schneider G; Clematide S
    J Biomed Inform; 2012 Oct; 45(5):851-61. PubMed ID: 22580177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ethical implications of stratifying by race in pharmacogenomics.
    Lee SS
    Clin Pharmacol Ther; 2007 Jan; 81(1):122-5. PubMed ID: 17186010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation and identification of reliable reference genes for pharmacogenomics, toxicogenomics, and small RNA expression analysis.
    Chen D; Pan X; Xiao P; Farwell MA; Zhang B
    J Cell Physiol; 2011 Oct; 226(10):2469-77. PubMed ID: 21412770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic databases and their potential in pharmacogenomics.
    Lagoumintzis G; Poulas K; Patrinos GP
    Curr Pharm Des; 2010; 16(20):2224-31. PubMed ID: 20459387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of pharmacogenomics for drug development.
    Kirk RJ; Hung JL; Horner SR; Perez JT
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1484-97. PubMed ID: 18849536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deciphering next-generation pharmacogenomics: an information technology perspective.
    Potamias G; Lakiotaki K; Katsila T; Lee MT; Topouzis S; Cooper DN; Patrinos GP
    Open Biol; 2014 Jul; 4(7):. PubMed ID: 25030607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA.
    Lesko LJ; Zineh I
    Pharmacogenomics; 2010 Apr; 11(4):507-12. PubMed ID: 20350131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translational bioinformatics approaches for systems and dynamical medicine.
    Yan Q
    Methods Mol Biol; 2014; 1175():19-34. PubMed ID: 25150864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of FDA guidance on pharmacogenomic data submissions on drug development.
    Little S
    IDrugs; 2005 Aug; 8(8):648-50. PubMed ID: 16044373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenomics and the drug discovery pipeline: when should it be implemented?
    Penny MA; McHale D
    Am J Pharmacogenomics; 2005; 5(1):53-62. PubMed ID: 15727489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of pharmacogenomics for drug development and clinical practice.
    Ginsburg GS; Konstance RP; Allsbrook JS; Schulman KA
    Arch Intern Med; 2005 Nov; 165(20):2331-6. PubMed ID: 16287761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promises of biomarkers in drug development--a reality check.
    Marrer E; Dieterle F
    Chem Biol Drug Des; 2007 Jun; 69(6):381-94. PubMed ID: 17581232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenomics.
    Ross JS; Schenkein DP; Kashala O; Linette GP; Stec J; Symmans WF; Pusztai L; Hortobagyi GN
    Adv Anat Pathol; 2004 Jul; 11(4):211-20. PubMed ID: 15220824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacogenetics II. Research molecular methods, bioinformatics and ethical concerns].
    Daudén E
    Actas Dermosifiliogr; 2007; 98(1):3-13. PubMed ID: 17374327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethics and policy perspectives on personalized medicine in the post-genomic era.
    Landon MR
    J Biolaw Bus; 2005; 8(3):28-36. PubMed ID: 16459425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of pharmacogenomics.
    Somogy A
    Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenomics: the promise of personalized medicine for CNS disorders.
    de Leon J
    Neuropsychopharmacology; 2009 Jan; 34(1):159-72. PubMed ID: 18800072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic databases in pharmacogenomics: the Frequency of Inherited Disorders Database (FINDbase).
    Georgitsi M; Patrinos GP
    Methods Mol Biol; 2013; 1015():321-36. PubMed ID: 23824866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of single-nucleotide polymorphism maps in pharmacogenomics.
    McCarthy JJ; Hilfiker R
    Nat Biotechnol; 2000 May; 18(5):505-8. PubMed ID: 10802616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New advances in pharmacogenomics.
    Destenaves B; Thomas F
    Curr Opin Chem Biol; 2000 Aug; 4(4):440-4. PubMed ID: 10959773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.